ACRV
Price
$1.35
Change
+$0.10 (+8.00%)
Updated
Jun 6 closing price
Capitalization
39.19M
61 days until earnings call
MGNX
Price
$1.78
Change
+$0.33 (+22.76%)
Updated
Jun 6 closing price
Capitalization
91.48M
65 days until earnings call
Interact to see
Advertisement

ACRV vs MGNX

Header iconACRV vs MGNX Comparison
Open Charts ACRV vs MGNXBanner chart's image
Acrivon Therapeutics
Price$1.35
Change+$0.10 (+8.00%)
Volume$688.59K
Capitalization39.19M
MacroGenics
Price$1.78
Change+$0.33 (+22.76%)
Volume$1.91M
Capitalization91.48M
ACRV vs MGNX Comparison Chart
Loading...
ACRV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MGNX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ACRV vs. MGNX commentary
Jun 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACRV is a StrongBuy and MGNX is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 09, 2025
Stock price -- (ACRV: $1.10 vs. MGNX: $1.39)
Brand notoriety: ACRV and MGNX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ACRV: 66% vs. MGNX: 60%
Market capitalization -- ACRV: $39.19M vs. MGNX: $91.48M
ACRV [@Biotechnology] is valued at $39.19M. MGNX’s [@Biotechnology] market capitalization is $91.48M. The market cap for tickers in the [@Biotechnology] industry ranges from $323.27B to $0. The average market capitalization across the [@Biotechnology] industry is $2.25B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ACRV’s FA Score shows that 1 FA rating(s) are green whileMGNX’s FA Score has 0 green FA rating(s).

  • ACRV’s FA Score: 1 green, 4 red.
  • MGNX’s FA Score: 0 green, 5 red.
According to our system of comparison, ACRV is a better buy in the long-term than MGNX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ACRV’s TA Score shows that 3 TA indicator(s) are bullish while MGNX’s TA Score has 5 bullish TA indicator(s).

  • ACRV’s TA Score: 3 bullish, 3 bearish.
  • MGNX’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, MGNX is a better buy in the short-term than ACRV.

Price Growth

ACRV (@Biotechnology) experienced а -4.35% price change this week, while MGNX (@Biotechnology) price change was -6.71% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.11%. For the same industry, the average monthly price growth was +10.01%, and the average quarterly price growth was -2.16%.

Reported Earning Dates

ACRV is expected to report earnings on Aug 08, 2025.

MGNX is expected to report earnings on Aug 12, 2025.

Industries' Descriptions

@Biotechnology (+4.11% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MGNX($91.5M) has a higher market cap than ACRV($39.2M). MGNX YTD gains are higher at: -57.231 vs. ACRV (-81.728). MGNX has higher annual earnings (EBITDA): -57.37M vs. ACRV (-84.45M). MGNX has more cash in the bank: 202M vs. ACRV (187M). ACRV has less debt than MGNX: ACRV (4.01M) vs MGNX (37.5M). MGNX has higher revenues than ACRV: MGNX (148M) vs ACRV (0).
ACRVMGNXACRV / MGNX
Capitalization39.2M91.5M43%
EBITDA-84.45M-57.37M147%
Gain YTD-81.728-57.231143%
P/E RatioN/AN/A-
Revenue0148M-
Total Cash187M202M93%
Total Debt4.01M37.5M11%
FUNDAMENTALS RATINGS
MGNX: Fundamental Ratings
MGNX
OUTLOOK RATING
1..100
62
VALUATION
overvalued / fair valued / undervalued
1..100
81
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
93
P/E GROWTH RATING
1..100
95
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ACRVMGNX
RSI
ODDS (%)
Bullish Trend 12 days ago
89%
N/A
Stochastic
ODDS (%)
Bullish Trend 12 days ago
83%
Bullish Trend 12 days ago
85%
Momentum
ODDS (%)
Bearish Trend 12 days ago
90%
Bearish Trend 12 days ago
88%
MACD
ODDS (%)
N/A
Bearish Trend 12 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 12 days ago
88%
Bearish Trend 12 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 12 days ago
84%
Bearish Trend 12 days ago
90%
Advances
ODDS (%)
Bullish Trend 20 days ago
87%
Bullish Trend 21 days ago
83%
Declines
ODDS (%)
Bearish Trend about 1 month ago
88%
Bearish Trend 12 days ago
87%
BollingerBands
ODDS (%)
N/A
Bullish Trend 12 days ago
84%
Aroon
ODDS (%)
Bearish Trend 12 days ago
84%
Bullish Trend 12 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
ACRV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MGNX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AAPL200.420.21
+0.10%
Apple
SPY587.73-3.42
-0.58%
SPDR® S&P 500® ETF
BTC.X107802.330000-1192.312500
-1.09%
Bitcoin cryptocurrency
TSLA356.90-5.99
-1.65%
Tesla
GME31.21-3.80
-10.85%
GameStop Corp

ACRV and

Correlation & Price change

A.I.dvisor indicates that over the last year, ACRV has been loosely correlated with ALLR. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if ACRV jumps, then ALLR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ACRV
1D Price
Change %
ACRV100%
N/A
ALLR - ACRV
46%
Loosely correlated
-2.33%
VERV - ACRV
39%
Loosely correlated
-1.17%
AURA - ACRV
38%
Loosely correlated
+0.17%
ARWR - ACRV
38%
Loosely correlated
+1.24%
MGNX - ACRV
37%
Loosely correlated
-6.40%
More

MGNX and

Correlation & Price change

A.I.dvisor indicates that over the last year, MGNX has been loosely correlated with NTLA. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if MGNX jumps, then NTLA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MGNX
1D Price
Change %
MGNX100%
-6.40%
NTLA - MGNX
48%
Loosely correlated
+3.59%
XNCR - MGNX
47%
Loosely correlated
-2.58%
FGEN - MGNX
46%
Loosely correlated
-1.09%
CRSP - MGNX
46%
Loosely correlated
-0.92%
NKTR - MGNX
44%
Loosely correlated
+3.68%
More